Retinoid therapy for psoriasis
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
This article focuses on the treatment of psoriasis with acitretin, the only systemic retinoid approved for psoriasis, and also briefly discusses its predecessor, etretinate, which was replaced by acitretin in 1997 and is no longer available. The use of topical tazarotene is also discussed in detail. Combination therapy of retinoids, both topical and systemic,with phototherapy and other therapeutic agents is described. In addition, new retinoid analogues that are undergoing clinical investigation are mentioned. Finally, potential toxicities and adverse effects associated with retinoids are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, retinoids have been reported to also be involved in several pathological situations: cardiovascular diseases, diabetes mellitus, obesity, osteoporosis, skin diseases and cancer [103,133,134,135,136,137,138,139].”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [137]
Citations
Cites
Greaves, M. W., & Weinstein, G. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320907 · Cited by 512
The retinoid signaling pathway: molecular and genetic analyses
Chambon, P. (1994) · Seminars in Cell Biology · doi:10.1006/scel.1994.1015 · Cited by 499
Treatment of psoriasis. Part 2. Systemic therapies
Lebwohl, M., & Ali, S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117047 · Cited by 199
Weinstein, G. D., Krueger, G. G., Lowe, N. J., Duvic, M., Friedman, D. J., Jegasothy, B. V., Jorizzo, J. L., Shmunes, E., Tschen, E. H., Lew-Kaya, D. A., et al. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70216-0 · Cited by 184 · cited 1×
“The most profound effect with tazarotene gel was the improvement of plaque elevation [36].”
BackgroundSelf-citationTazarotene-first of a new generation of receptor-selective retinoids
CHANDRARATNA, R. A. S. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb15662.x · Cited by 172 · cited 1×
“Tazarotenic acid selectively binds to retinoic acid receptors and exhibits little affinity for retinoid X receptors [11].”
BackgroundAcitretin plus UVB therapy for psoriasis
Lowe, N. J., Prystowsky, J. H., Bourget, T., Edelstein, J., Nychay, S., & Armstrong, R. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70089-k · Cited by 167 · cited 2×
“Acitretin plus UVB therapy is another combination form of therapy to treat psoriasis and has been investigated [28–30].”
BackgroundSelf-citationTanew, A., Guggenbichler, A., Hönigsmann, H., Geiger, J. M., & Fritsch, P. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70253-x · Cited by 162 · cited 2×
“The concomitant use of PUVA with acitretin has been studied by several investigators [21–27].”
BackgroundSaurat, J.-H., Geiger, J.-M., Amblard, P., Beani, J.-C., Boulanger, A., Claudy, A., Frenk, E., Guilhou, J.-J., Grosshans, E., Mérot, Y., et al. (1988) · Dermatology · doi:10.1159/000248567 · Cited by 148 · cited 2×
“The concomitant use of PUVA with acitretin has been studied by several investigators [21–27].”
BackgroundResultTazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis
Lebwohl, M., Breneman, D., Goffe, B. S., Grossman, J. R., LING, M. R., Milbauer, J. J., Pincus, S. H., Sibbald, R. G., Swinyer, L. J., Weinstein, G. D., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70008-8 · Cited by 142
Weinstein, G. D., Koo, J. Y. M., Krueger, G. G., Lebwohl, M., Lowe, N. J., Menter, A., Lew‐Kaya, D. A., Sefton, J., Gibson, J. R., & Walker, P. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.103 · Cited by 137
Self-citation
Research works printed but not linked: 1
- Jensen, 1992, Clinical evidence that acitretin is esterified to etretinate when administered with ethanol [abstract], FASEB J, 6, A1570
Cited by
Overview of retinoid metabolism and function
Blomhoff, R., & Blomhoff, H. K. (2006) · Journal of Neurobiology · doi:10.1002/neu.20242 · Cited by 947
Carazo, A., Macáková, K., Matoušová, K., Krčmová, L. K., Protti, M., & Mladěnka, P. (2021) · Nutrients · doi:10.3390/nu13051703 · Cited by 461
British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
Ormerod, A. D., Campalani, E., & Goodfield, M. J. D. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09755.x · Cited by 167
Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine
Warren, R. B., & Griffiths, C. E. M. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.11.006 · Cited by 112
Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology
van de Kerkhof, P. C. M. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2006.00082.x · Cited by 85
Metadata
- Authors
- Yamauchi, P. S., Rizk, D., & Lowe, N. J.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Lowe, Nicholas J.
- ORCID
- Lowe, Nicholas J.
- Venue
- Dermatologic Clinics
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 22
- Issue
- 4
- Pages
- 467-476
- ISSN
- 0733-8635 (ISSN-L)
- OpenAlex
- W2140865108
- Cited by
- 43
- References
- 43
- Citations by year
- 2026: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Dermatologic Clinics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
- Keywords
- psoriasis, retinoids, acitretin, etretinate, tazarotene, topical retinoids, systemic retinoids, combination therapy, phototherapy, retinoid analogues, adverse effects, drug toxicity
- MeSH terms
- Administration, Oral, Administration, Topical, Combined Modality Therapy, Dermatologic Agents, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Male, Prognosis, Psoriasis, PUVA Therapy, Retinoids, Severity of Illness Index, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinoid therapy for psoriasis. https://app.cochat.ai/papers/10.1016/s0733-8635(03)00126-8
- The paper
- Yamauchi, P. S., Rizk, D., & Lowe, N. J. (2004). Retinoid therapy for psoriasis. Dermatologic Clinics. https://doi.org/10.1016/s0733-8635(03)00126-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.